Pharmaceuticals Global On demand · 24-48h

Global Sulforaphane Market Strategic Research Report

Global Sulforaphane Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Sulforaphane Market
$6.062025
5.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 0.1% -1%, 1%-10%, Others

By Application: Health Care Products, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: VIO Chemicals, CS Health, Mara Labs, Triballat Noyal, Nutramax Laboratories Consumer Care, Jarrow Formulas, Pioneer Herb Industrial, Fushan Biotech, Brassica Protection Products

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 98 pages
Market size 2025
$6.06
Million USD
Forecast CAGR
5.6%
2025-2032
Forecast 2032
$8.9
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Sulforaphane market size is predicted to grow from US$ 6.06 million in 2025 to US$ 8.83 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

Sulforaphane (SFN), also known as sulforaphane, is an isothiocyanate obtained by hydrolysis of glucosinolate by myrosinase in plants, and often exists in a stable form of glucoraphanin. Sulforaphane appears as a light yellow powder or a yellow-brown oily liquid. It is abundant in cruciferous vegetables and bean sprouts, such as broccoli, kale, cauliflower, northern round carrots, cabbage, kale, etc., among which broccoli sprouts have the highest concentration of sulforaphane. Sulforaphane, as an important anticancer compound in cruciferous vegetables (such as broccoli, Brussels sprouts, cabbage, etc.), is widely used in health products, medicines, nutritional supplements, functional foods, beverages and cosmeceuticals due to its significant antioxidant, anti-inflammatory and anti-cancer pharmacological activities. As one of the plant active substances, sulforaphane has multiple functions such as anticancer, antibacterial, anti-inflammatory, nerve protection, and anti-aging. It has shown good application prospects in the fields of biomedicine, cosmetics, health products, food, etc. Sulforaphane is one of the most effective active substances in vegetables for cancer prevention. It has a good preventive effect on esophageal cancer, colon cancer, breast cancer, liver cancer, colorectal cancer, etc. Sulforaphane can be used to develop anti-cancer drugs. Currently, more than 100 human clinical trials on sulforaphane have been conducted worldwide. In the future, sulforaphane may become the next dark horse in the medical field.

Global key players of sulforaphane include CS Health, Pioneer Herb Industrial, Triballat Noyal, etc. The top three players hold a share about 52%. Globally, the sulforaphane market is mainly concentrated in the United States, Europe, China and other regions, among which North America is the world's largest consumer market. China is one of the world's major suppliers of sulforaphane. Currently, domestic companies engaged in the research and production of sulforaphane include Pioneer Herb Industrial and Shenzhen Fushan Biotechnology, etc.

This report presents a comprehensive overview of the global Sulforaphane market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Concentration

  • 0.1% -1%
  • 1%-10%
  • Others

Segment by Application

  • Health Care Products
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Sulforaphane market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Health Care Products, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Sulforaphane Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$6.06
2025
Forecast
$8.9
2032
CAGR
5.6%
2025–2032
영역들
5
global
Key companies
VIO ChemicalsCS HealthMara LabsTriballat NoyalNutramax Laboratories Consumer CareJarrow FormulasPioneer Herb IndustrialFushan Biotech
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
0.1% -1%1%-10%Others
By Application
Health Care ProductsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 0.1% -1%
  • 3.1.3 1%-10%
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Health Care Products
  • 4.1.3 Others
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 VIO Chemicals
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 CS Health
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Mara Labs
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Triballat Noyal
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Nutramax Laboratories Consumer Care
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Jarrow Formulas
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Pioneer Herb Industrial
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Fushan Biotech
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Brassica Protection Products
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Sulforaphane market?
The global Sulforaphane market is estimated at US$ 6.06 million in 2025 (base year) and is projected to reach US$ 8.83 million by 2032.
What is the forecast CAGR for the Sulforaphane market?
The market is expected to grow at a CAGR of 5.6% from 2026 to 2032, expanding from US$ 6.06 million in 2025 to US$ 8.83 million in 2032, roughly 1.5 times its base-year value.
What is Sulforaphane?
Sulforaphane (SFN), also known as sulforaphane, is an isothiocyanate obtained by hydrolysis of glucosinolate by myrosinase in plants, and often exists in a stable form of glucoraphanin. Sulforaphane appears as a light yellow powder or a yellow-brown oily liquid. It is abundant in cruciferous vegetables and bean sprouts, such as broccoli, kale, cauliflower, northern round carrots, cabbage, kale, etc., among which broccoli sprouts have the highest concentration of sulforaphane.
How is the Sulforaphane market segmented by concentration?
By concentration, the market is segmented into 0.1% -1%, 1%-10% and Others.
What are the key applications of Sulforaphane?
Key applications covered include Health Care Products and Others.
Which companies are profiled in the Sulforaphane market report?
Key players profiled include VIO Chemicals, CS Health, Mara Labs, Triballat Noyal, Nutramax Laboratories Consumer Care, Jarrow Formulas, Pioneer Herb Industrial and Fushan Biotech, among 9 companies covered in total.
What geographies does the Sulforaphane market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Sulforaphane market report?
The report is intended for manufacturers and solution providers, distributors and end users in Health Care Products and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Sulforaphane market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.